The adenovirus E1A and E1B19K genes provide a helper function for transfection-based adeno-associated virus vector production

被引:24
作者
Matsushita, T
Okada, T
Inaba, T
Mizukami, H
Ozawa, K
Cojosi, P
机构
[1] Jichi Med Sch, Ctr Mol Med, Div Genet Therapeut, Kawachi, Tochigi 3290489, Japan
[2] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Mol Oncol, Hiroshima 7348553, Japan
[3] Avigen Inc, Alameda, CA USA
关键词
D O I
10.1099/vir.0.79940-0
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Although the adenoviral Ell, E2A, E4 and VA RNA regions are required for efficient adeno-associated virus (AAV) vector production, the role that the individual Ell genes (E1A, E1B19K, E1B55K and protein IX) play in AAV vector production has not been clearly determined. Ell mutants were analysed for their ability to mediate AAV vector production in HeLa or KB cells, when cotransfected with plasmids encoding all other packaging functions. Disruption of E1A and E1B19K genes resulted in vector yield reduction by up to 10- and 1 00-fold, respectively, relative to the wild-type Ell. Interruption of the E1B55K and protein IX genes had a modest effect on vector production. Interestingly, expression of anti-apoptotic E1B19K cellular homologues such as BcI-2 or Bcl-X-L fully complemented E1B19K mutants for AAV vector production. These findings may be valuable for the future development of packaging cell lines for AAV vector production.
引用
收藏
页码:2209 / 2214
页数:6
相关论文
共 31 条
[21]   ADENO-ASSOCIATED VIRUS P5 PROMOTER CONTAINS AN ADENOVIRUS E1A-INDUCIBLE ELEMENT AND A BINDING-SITE FOR THE MAJOR LATE TRANSCRIPTION FACTOR [J].
CHANG, LS ;
SHI, Y ;
SHENK, T .
JOURNAL OF VIROLOGY, 1989, 63 (08) :3479-3488
[22]   A single intramuscular injection of recombinant adeno-associated virus vector encoding apo A-1 Milano gene inhibits atherosclerosis in apo E-null mice [J].
Shah, PK ;
Hardy, S ;
Yano, J ;
Wong, KK .
CIRCULATION, 2004, 110 (17) :330-330
[23]   DELAY OF VACCINIA VIRUS-INDUCED APOPTOSIS IN NONPERMISSIVE CHINESE-HAMSTER OVARY CELLS BY THE COWPOX VIRUS CHOHR AND ADENOVIRUS E1B 19K GENES [J].
INK, BS ;
GILBERT, CS ;
EVAN, GI .
JOURNAL OF VIROLOGY, 1995, 69 (02) :661-668
[24]   Transplantation of a Novel Recombinant Adeno-Associated Virus (pAAV-HE1B19K-TE1A) Demonstrates Higher Anti-Tumor Effects in Tumor Cells [J].
Li, Zhuo-Qing ;
Shen, Hong ;
Shu, Kun-Xian ;
Li, Jian-Jun ;
Tang, Yin ;
Su, Jing-Jing ;
Yan, Jun ;
Yang, Jie ;
Wang, Ze-Qing ;
Qiu, Yan ;
Yang, Yong ;
Liu, Yang ;
Zhou, Yong .
ANNALS OF TRANSPLANTATION, 2020, 25 :1-10
[25]   Adeno-associated virus, a popular gene therapy vector, encodes a "classical" antioncoprotein:: AAV Rep78 directly binds to HPV-16 E7, Ad E1A, and simian virus 40 large T antigen in vivo, and has additional antioncogenic activities as well [J].
Hermonat, PL ;
Zhan, DJ .
CANCER GENE THERAPY, 1998, 5 (06) :S26-S27
[26]   Adenovirus sensitizes pancreatic cancer cells to DNA-damaging chemotherapeutics through mitotic catastrophe induction and this is further enhanced by the deletion of the anti-apoptotic E1B19K gene [J].
Pantelidou, C. ;
Cherubini, G. ;
Lemoine, N. R. ;
Hallden, G. .
HUMAN GENE THERAPY, 2011, 22 (10) :A119-A120
[27]   E4Orf6-E1B-55k-dependent degradation of de novo-generated adeno-associated virus type 5 Rep52 and capsid proteins employs a cullin 5-containing E3 ligase complex [J].
Nayak, Ramnath ;
Farris, K. David ;
Pintel, David J. .
JOURNAL OF VIROLOGY, 2008, 82 (07) :3803-3808
[28]   Human lymphoid tumor cells transduced with recombinant adeno-associated virus (AAV) vectors containing B7-1 and B7-2 genes provide potent costimulatory signals for T cell proliferation. [J].
Hallek, M ;
Wendtner, CM ;
Mangold, E ;
Nolte, A ;
BraunFalco, M ;
Chiorini, JA ;
Kotin, RM ;
Maass, G ;
Emmerich, B ;
Winnacker, EL .
BLOOD, 1995, 86 (10) :3984-3984
[29]   SIMIAN VIRUS-40 LARGE-T ANTIGEN EXPRESSES A BIOLOGICAL-ACTIVITY COMPLEMENTARY TO THE P300-ASSOCIATED TRANSFORMING FUNCTION OF THE ADENOVIRUS E1A GENE-PRODUCTS [J].
YACIUK, P ;
CARTER, MC ;
PIPAS, JM ;
MORAN, E .
MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (04) :2116-2124
[30]   Update on a phase 1/2 open-label trial of BAX335, an adeno-associated virus 8 (AAV8) vector-based gene therapy program for hemophilia B [J].
Monahan, P. ;
Walsh, C. E. ;
Powell, J. S. ;
Konkle, B. A. ;
Josephson, N. C. ;
Escobar, M. ;
McPhee, S. J. ;
Litchev, B. ;
Cecerle, M. ;
Ewenstein, B. M. ;
Rottensteiner, H. ;
Rosa, M. D. L. ;
Reipert, B. M. ;
Samulski, R. J. ;
Orloff, J. ;
Scheiflinger, F. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 :87-87